Opioids: The Cause of, and Solution
|
|
- Linda Ball
- 5 years ago
- Views:
Transcription
1 Opioids: The Cause of, and Solution to, All Things Pain Tina Korownyk & Jessica Kirkwood Faculty/Presenter Disclosure Presenter: Tina Korownyk Relationships that may introduce potential bias and/or conflict of interest: Grants/Research Support: Program/project funding received from non profit sources Alberta College of Family Physicians, other provincial chapters of the CFPC, Toward Optimized Practice Speakers Bureau/Honoraria: Tina Korownyk has received a speaker fee and expense support from the Alberta College of Family Physicians. Consulting Fees: N/A Other: Paid by University of Alberta, Alberta Health 1
2 Faculty/Presenter Disclosure Presenter: Jessica Kirkwood Relationships that may introduce potential bias and/or conflict of interest: Grants/Research Support: N/A Speakers Bureau/Honoraria: Jessica Kirkwood has received a speaker fee and expense support from the Alberta College of Family Physicians. Consulting Fees: N/A Other: N/A Disclosure of Commercial Support This program is presented by the Alberta College of Family Physicians (ACFP) without any commercial or in kind support. The ACFP provides a speaker fee and expense support for presenting at the Practical Evidence for Informed Practice. 2
3 Objectives Discuss evidence for opioids in Acute pain Do they work? For what? How long? Chronic pain Long term risks and benefits Tapering Practical Suggestions Troubleshooting 2017 Chronic Non Cancer Pain Guidelines Average Jo Psychiatric Concerns Substance Abuse ABO Ok, opioids Aim < 50mg/d Treat psych Treat substance abuse Ok, no more than 90mg/d Rotate Opioids Refer to Formal Multidisciplinary Program Titrate down 3
4 2017 Chronic Non Cancer Pain Guidelines Average Jo Psychiatric Concerns Substance Abuse ABO Ok, opioids Aim < 50mg/d Treat psych Treat substance abuse Ok, no more than 90mg/d Rotate Opioids Refer to Formal Multidisciplinary Program Titrate down X X 4
5 CMAJ Oct 2016 Pediatric Acute Pain Management MSK Injuries 1 : 3 RCTs, 740 children, ibuprofen vs aceta, codeine, or both Ibuprofen > either alone for pain, ibuprofen = combination Ibuprofen improved function, fewer AEs RCT 134 kids, ibuprofen (10mg/kg) vs morphine (0.5mg/kg) No difference pain scores 24 hrs Morphine AE 56% vs 31%, NNH = 4 Outpatient Post Operative Pain RCT 154 children, orthopedic surgery (ORIF, cysts, hardward removal) Ibuprofen vs Morphine 2 No difference pain scores up to 48 hrs Morphine NNH = 4 Similar for post tonsillectomy pain 3 1) TFP #14, updated July , CMAJ DOI: ) CMAJ 2017 October 10;189:E ) Pediatrics 2015;135:
6 Legitimate opioid use before high school was independently associated with a 33% risk future opioid misuse after high school. Pediatrics Nov;136(5):e Acute Pain in Adults Adult Back Pain < 2 weeks 2 : RCT, Naprosyn 500 BID: + cyclobenzaprine 5mg, oxycodone/acetaminophen 5/325mg, or placebo (1 2 TID) No difference frequent/always back pain day 6: 29%, 28%, 35% Return to normal activities: 4d, 4d and 5d. Soft Tissue Injury 3 : Cochrane (4 RCTs, 958 pts): No difference opioid vs NSAID for pain outcomes Improved function at 7d with NSAIDs. MVC Pain 4 : ER Cohort: NSAID vs Opioid no difference in pain at 6 weeks Those prescribed opioids 20% more likely to report opioid use at 6 weeks Labour 5 : Insufficient evidence that parenteral opioids are more effective than placebo or other interventions 2) JAMA. 2015;314(15): ) Ann Intern Med Feb 16;164(4):JC19.. 3) Cochrane Database Syst Rev Jul 1;(7):CD ) Pain Feb;158(2): ) Cochrane Database Syst Rev Mar 14;(3):CD
7 How Many Opioids Do We Need? Ann Surg Apr;265(4): How Many Opioids Do We Need? Post op: 80% of patient requirements met by 5 15 pills Ann Surg Apr;265(4):
8 Unused Opioids After Surgery Up to 71% of opioid tablets prescribed were unused 1 Among persons who were abusing analgesics, 53% reported receiving them from a friend or relative 2 JAMA Surg Aug 2. doi: /jamasurg ) Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings. NSDUH series H 48. HHS publication no. (SMA) Rockville, MD Opioid Sparing Effects of NSAIDs 1 Pediatric Sys Rev 1 : 27 RCTs Perioperative NSAID consumption opioid requirement in first 24 hrs SMD = 0.83 (Large effect) 1 Adult Sys Rev + Network Meta Analysis 2 : Post op NSAID + Acetaminophen morphine requirement by 23mg/24hr (CI 14 32) 1) Anesth Analg 2012;114: ) Br J Anaesth Jan;118(1):
9 Bottom Line Acute Pain Ambulatory care: no strong evidence that opioids are superior 1 If opioids prescribed, most will not require more than 5 15 tablets Consider addition of NSAIDs/Acetaminophen to reduce opioid consumption 1) Ann Emerg Med Oct;60(4): ) 3) mdacep org/md%20acep%20pamphlet%20final April% pdf Are Long Acting Opioids Better? Study Pain Time Pts Findings Oxycodone Systematic Review: 7 RCTs, 568 pts, short vs Caldwell 1999 OA 30d 107 Equal for pain and sleep long acting opioids Hale 1999 Back 6d 47 Equal for pain No difference pain or functional outcomes Salzman 1999 Back 10d 57 Equal for pain Codeine Hale 1997 Back 5d 83 LA better pain (but higher doses)* 200mg vs 71mg / day Dihydrocodeine Gostick 1989 Back 14d 61 Equal for pain Lloyd 1992 OA 14d 86 Equal for pain Morphine Jamison 1998 Back 112d 36 LA better pain (but higher doses) * Carson S, Thakurta S, Low A, Smith B, Chou R. Drug Class Review: LA group Long Acting titrated Opioid up Analgesics: as needed Final Update 6 Report. Portland, OR: Oregon Health and Science University; July Accessed Oct
10 CMAJ Dec 8;181(12): Long Vs Short Acting Opioids Cohort, 319 Unintentional Overdoses, veterans admin healthcare system 1 Risk Overdose with long acting: HR 2.33 Highest in 1 st 2 weeks: HR 5.25 Mortality with Long acting compared to other pain medications 2 Because of the greater risks of overdose and death with extended release opioid formulations, reserve [these medications] for use in patients for whom alternative treatment options (e.g. non opioid analgesics or immediate release opioids) are ineffective (FDA 2013) 1) JAMA Intern Med. 2015;175(4): ) JAMA. 2016;315:
11 Benefits and Risks of a long term commitment 11
12 Opioids for Chronic Pain Abuse or dependence 1 : 0.7% with 36 MME/d, 6.1% with 120 MME/d Overdose 1 : risk with dose: MME/d HR MME/d HR 3.79 >100 MME/d HR 8.87 Road trauma: ~ 20% odds with 20MME/d 2 Mortality: (LA Opioid vs TCA or anticonvulsant) 3 <30 d: 260/10,000 vs 63/10,000 (HR = 4.16) Overall: 167/10,000 vs 108/10,000 (HR = 1.64) Mixed evidence for fractures, MI, & sexual dysfunction 1) Dowell D, Haegerich TM, Chou R. CDC Guideline for Prescribing Opioids for Chronic Pain United States, MMWR Recomm Rep 2016;65(No. RR 1): ) JAMA Intern Med 2013;173: ) JAMA. 2016;315: Opioids for Chronic Pain Cochrane systematic reviews Chronic back pain 1 : Majority < 4weeks, opioids better than placebo, no better than NSAIDs or antidepressants Neurologic pain 2 : half the studies <24hrs. Opioids > placebo for pain but not function. No diff with gabapentin or TCAs OA pain 3 : small benefit vs placebo, trials <4 weeks demonstrated significantly greater pain benefit (p=0.001) Sys Rev, opioids >3 mo 4 No placebo controlled RCTs > 3 months No study opioids vs no opioids evaluated >1 yr outcomes of pain, function or quality of life. 2) Cochrane 2013; 8: CD ) Cochrane Database of Systematic Reviews 2013, CD ) Cochrane 2014; 9: CD ) Ann Intern Med Feb 17;162(4):
13 Opioids for Chronic Pain As highlighted by an on the National Institutes of Health Pathways to Prevention panel: Particularly striking was the realization that evidence is insufficient for every clinical decision that a provider needs to make about the use of opioids for chronic pain. Bottom Line: Evidence of long term benefit on pain, function and QOL with opioids is lacking. Ann Intern Med 2015;162: Is Tapering Actually Helpful? Sys Rev 67 studies, opioid d/c or Voluntary: Multidisciplinary Pain Clinic, Buprenorphine, Behavorial interventions, Detox, Ketamine, Accupuncture, or Other Patient Outcomes (fair quality studies): 8/8 reported Pain severity 5/5 reported Function 3/3 reported QOL Limitations: Observational, absolute benefit unclear, a/es poorly reported, heterogeneous interventions, applicability to forced tapering? CDC: Evidence on tapering strategy or benefit too limited to make recommendations Ann Intern Med Aug 1;167(3): ) Dowell D, Haegerich TM, Chou R. CDC Guideline for Prescribing Opioids for Chronic Pain United States, MMWR Recomm Rep 2016;65(No. RR 1):1 49. DOI: 13
14 Whoooo are you? Ready Set Go! 14
15 STOP! BEFORE you sign that Rx: Discuss alternatives Discuss side effects Review goals (focus on fxn!) Opioid Contract UTT? (Urine Drug Screen) Opioid Contract Who pt, sole prescriber/clinic What med, dose, route Where single pharmacy When dispensing interval Why what are we treating, goals Won t divert, store unsafely, combine with harmful substances (etoh, benzos, other opiates, etc) come begging for more when I drop them down a storm drain, etc. Wee Routine UTTs 15
16 Acute Pain Specific end date (sunrise, sunset) Reconsider length of Rx is 2 weeks or 30 tabs really necessary? Review dispensing interval, storage, disposal How you doin? How to tell when it s going well Function function function!! Attending appts, not breaching opioid contract Decrease? 16
17 How you doin? How to tell when it s going well Function function function!! Attending appts, not breaching opioid contract Decrease? How you doin? How to tell when things are going poorly Listen to your gut Escalating doses with no perceived benefit Concerns re: misuse Early releases Missed appts Reports from colleagues Evidence of dependence A problematic pattern of opioid use leading to significant impairment or distress 17
18 Now what? If no evidence of OUD Rotate Taper Discuss benefits of tapering (improved energy, decreased side effects, improved pain control) Optimize non opiate pain management Set realistic function goals Optimize psychosocial supports Create a schedule (5 10% every 2 4 weeks) Frequent follow up Now what? If no evidence of OUD Rotate Taper Discuss benefits of tapering (improved energy, decreased side effects, improved pain control) Optimize non opiate pain management Set realistic function goals Optimize psychosocial supports Create a schedule (5 10% every 2 4 weeks) Frequent follow up 18
19 Now what? If you suspect OUD Discuss concerns and suggest voluntary taper with psychosocial supports Discuss Methadone or Suboxone Physician or self referral Phone a friend! Consult a colleague Opioid Dependency Telephone Consultation RAAPID North RAAPID South Thank you! 19
Managing Back Pain. Faculty/Presenter Disclosure
Managing Back Pain G. Michael Allan Evidence & CPD Program, Alberta College of Family Physicians Professor, Dept Family Med, U of A. Faculty/Presenter Disclosure Faculty/Presenter: G. Michael Allan Relationships
More informationNew, True & Poo. Faculty/Presenter Disclosure
New, True & Poo Unpleasant Truths Comforting Lies Tina, Mike K, Adrienne, Mike A, Evidence & CPD Program, Alberta College of Family Physicians Department of Family Medicine, University of Alberta Faculty/Presenter
More informationClinical and Contextual Evidence Reviews
Clinical and Contextual Evidence Reviews Roger Chou, MD Professor of Medicine Oregon Health & Science University Director, Pacific Northwest Evidence-based Practice Center Purpose Summarize methods for
More informationIs Depression management getting you down? G. Michael Allan Director Programs and Practice Support, CFPC Professor, Family Med, U of A
Is Depression management getting you down? G. Michael Allan Director Programs and Practice Support, CFPC Professor, Family Med, U of A Faculty/Presenter Disclosures Faculty: Mike Allan Salary: College
More informationIs Depression management getting you down? G. Michael Allan Director Programs and Practice Support, CFPC Professor, Family Med, U of A
Is Depression management getting you down? G. Michael Allan Director Programs and Practice Support, CFPC Professor, Family Med, U of A Faculty/Presenter Disclosures Faculty: Mike Allan Salary: College
More informationA Gathering Storm: Evaluating Perioperative Opioids
A Gathering Storm: Evaluating Perioperative Opioids Michael Bottros, MD Disclosure Nothing to disclose 1 Learning Objectives Describe the history of opioid prescribing practices in the United States Describe
More informationA Gathering Storm: Evaluating Perioperative Opioids
A Gathering Storm: Evaluating Perioperative Opioids Michael Bottros, MD Disclosure Nothing to disclose 1 Objectives Describe the history of opioid prescribing practices in the United States Describe the
More informationPain Management and Safe use of opioids in hospitals. Kyoung-Sil Kang, PharmD, BCPS Scott Tam, PharmD Lauve Casimir, RN, MSN
Pain Management and Safe use of opioids in hospitals Kyoung-Sil Kang, PharmD, BCPS Scott Tam, PharmD Lauve Casimir, RN, MSN Bronx Care Health System Bronx Lebanon Hospital Concourse/ Fulton division, Nursing
More informationDr. G. Michael (Michael) Allan EDMONTON AB Dr. Christina (Tina) S. Korownyk EDMONTON AB MEDICAL CANNABANOIDS IN PRIMARY CARE
Society of Rural Physicians of Canada 26TH ANNUAL RURAL AND REMOTE MEDICINE COURSE ST. JOHN'S NEWFOUNDLAND AND LABRADOR APRIL 12-14, 2018 262 Dr. G. Michael (Michael) Allan EDMONTON AB Dr. Christina (Tina)
More informationOpiate Use Disorder and Opiate Overdose
Opiate Use Disorder and Opiate Overdose Irene Ortiz, MD Medical Director Molina Healthcare of New Mexico and South Carolina Clinical Professor University of New Mexico School of Medicine Objectives DSM-5
More informationStandard of Practice for Prescribing Opioids (Excluding Cancer, Palliative, and End-of-Life Care)
Standard of Practice for Prescribing Opioids (Excluding Cancer, Palliative, and End-of-Life Care) Preamble This Standard establishes the standards of practice and ethical requirements of all physicians
More informationLearning Objectives. Perioperative goals. Acute Pain in the Chronic Pain Patient for Ambulatory Surgery 9/8/16
Acute Pain in the Chronic Pain Patient for Ambulatory Surgery Danielle Ludwin, MD Associate Professor of Anesthesiology Division of Regional and Orthopedic Anesthesia Columbia University Medical Center
More informationBree Collaborative AMDG Opioid Prescribing Guidelines Workgroup. Opioid Prescribing Metrics - DRAFT
Bree Collaborative AMDG Opioid Prescribing Guidelines Workgroup Opioid Prescribing Metrics - DRAFT Definitions: Days Supply: The total of all opioid prescriptions dispensed during the calendar quarter
More information5 Things to Know About Irritable Bowel Syndrome
5 Things to Know About Irritable Bowel Syndrome Mike Kolber MD, CCFP, MSc PEIP 2017 Faculty/Presenter Disclosure Presenter: Mike Kolber Relationships that may introduce potential bias and/or conflict of
More informationBest Practices in Prescribing Opioids for Chronic Non-cancer Pain
Best Practices in Prescribing Opioids for Chronic Non-cancer Pain Disclosures S C O T T S T E I G E R, M D, F A C P, D A B A M A S S I S T A N T C L I N I C A L P R O F E S S O R D I V I S I O N O F G
More informationOpioid Review and MAT Clinic CDC Guidelines
1 Opioid Review and MAT Clinic CDC Guidelines January 10, 2018 Housekeeping Use chat feature to inform everyone who s at your clinic Click chat on Zoom option bar Chat Everyone the names of those who are
More informationDealing with acute pain in older patients
Balanced information for better care Dealing with acute pain in older patients Current evidence on effective, safe strategies Acute pain (< 9 days) usually resolves rapidly, even without intervention FIGURE
More informationManagement of high risk MMT patients. Meldon Kahan MD Methadone Prescribers Conference Toronto, Nov 15, 2013
Management of high risk MMT patients Meldon Kahan MD Methadone Prescribers Conference Toronto, Nov 15, 2013 CFPC CoI Templates: Slide 1 Faculty Disclosure Faculty: Meldon Kahan Relationships with commercial
More informationBuilding capacity for a CHC response to Ontario's Opioid Crisis
Building capacity for a CHC response to Ontario's Opioid Crisis Rob Boyd Oasis Program Director Luc Cormier, RN, MScN Community Health Nurse Sandy Hill Community Health Centre #AOHC2016 @rboyd6 @SandyHillCHC
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: Opioid Analgesics Reference Number: HIM.PA.139 Effective Date: 12.01.17 Last Review Date: 11.17 Line of Business: Health Insurance Marketplace Revision Log See Important Reminder at the
More informationWisconsin Opioid Prescribing Guideline Draft Scope and purpose of the guideline
Wisconsin Opioid Prescribing Guideline Draft Scope and purpose of the guideline: To help providers make informed decisions about acute and chronic pain treatment -pain lasting longer than three months
More informationUnitedHealthcare Pharmacy Clinical Pharmacy Programs
UnitedHealthcare Pharmacy Clinical Pharmacy Programs Program Number 2018 P 4000-3 Program Opioid Overutilization Cumulative Drug Utilization Review Criteria Medication Includes all salt forms, single and
More informationAcademic Medical School: Implementing Curriculum in Chronic Pain and Opioid Misuse. Jill M Williams, MD
Academic Medical School: Implementing Curriculum in Chronic Pain and Opioid Misuse Pain, Pain Management and the Opioid Epidemic Symposium Jill M Williams, MD Professor Psychiatry Director, Division Addiction
More informationRule Governing the Prescribing of Opioids for Pain
Rule Governing the Prescribing of Opioids for Pain 1.0 Authority This rule is adopted pursuant to Sections 14(e) and 11(e) of Act 75 (2013) and Sections 2(e) and 2a of Act 173 (2016). 2.0 Purpose This
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: Reference Number: HIM.PA.139 Effective Date: 12.01.17 Last Review Date: 02.18 Line of Business: Health Insurance Marketplace Revision Log See Important Reminder at the end of this policy
More informationOpioid Step Policy. Description. Section: Prescription Drugs Effective Date: April 1, 2018
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Opioid Step Policy Page: 1 of 6 Last Review Date: March 16, 2018 Opioid Step Policy Description
More informationAs part of the Opioid Analgesic REMS, all opioid analgesic companies must provide the following:
Introduction FDA s Opioid Analgesic REMS Education Blueprint for Health Care Providers Involved in the Treatment and Monitoring of Patients with Pain (January 2018) Background In July 2012, FDA approved
More informationThe Role of Dentists in Preventing Opioid Abuse Tufts Health Care Institute Program on Opioid Risk Management 12 th Summit Meeting March 11-12, 2010
The Role of Dentists in Preventing Opioid Abuse Tufts Health Care Institute Program on Opioid Risk Management 12 th Summit Meeting March 11-12, 2010 EXECUTIVE SUMMARY It is well documented in multiple
More informationUnderstanding and Combating the Heroin Epidemic
Understanding and Combating the Heroin Epidemic Kelly Dunn, Ph.D. Assistant Professor; Johns Hopkins School of Medicine Department of Psychiatry and Behavioral Sciences 1 Talk Outline What is causing the
More informationTeaming Up for Safer Pain Management: Strategies for Effective Collaboration
Teaming Up for Safer Pain Management: Strategies for Effective Collaboration Noah Nesin, MD, FAAFP, Vice President of Medical Affairs, Penobscot Community Health Care Felicity Homsted, PharmD, DPLA, Chief
More informationOPIOID USE DISORDER AND THE PSYCHIATRIC EMERGENCY ROOM THE VA CT MODEL
OPIOID USE DISORDER AND THE PSYCHIATRIC EMERGENCY ROOM THE VA CT MODEL Brian Fuehrlein, MD PhD VA Connecticut Healthcare System and Yale University I have no conflicts of interest or relevant financial
More informationChronic Pain Pharmacist role in the clinic
Chronic Pain Pharmacist role in the clinic WSPA Annual Meeting 2015 Alvin Goo, PharmD Clinical Associate Professor University of Washington Schools of Pharmacy and Family Medicine Speakers Declaration
More informationIMPLEMENTATION OF A SHARED MEDICAL APPOINTMENT FOR OPIOID OVERDOSE EDUCATION AND NALOXONE KIT TRAINING FOR VETERANS Kristin A. Tallman, Pharm.
IMPLEMENTATION OF A SHARED MEDICAL APPOINTMENT FOR OPIOID OVERDOSE EDUCATION AND NALOXONE KIT TRAINING FOR VETERANS Kristin A. Tallman, Pharm.D, BCPS Clinical Pharmacy Specialist Providence Medical Group
More informationCLINICAL POLICY Clinical Policy: Extended Release Opioid Analgesics
Reference Number: AZ.CP.PMN.97 Effective Date: 02.11 Last Review Date: 02.18 Line of Business: Medicaid- AHCCCS Revision Log See Important Reminder at the end of this policy for important regulatory and
More informationFaculty/Presenter Disclosure
Weight loss & Obesity WHAT S NEW & EXCITING? Tina Korownyk Dept of Family Medicine, UofA Faculty/Presenter Disclosure Faculty/Presenter: Tina Korownyk Relationships with commercial interests: None 1 Drowning
More informationOpioids and Chronic Pain: Case studies and Personal Experience
Opioids and Chronic Pain: Case studies and Personal Experience Dr Rupa Patel, MD, CCFP, FCFP Assistant Professor, Department of Family Medicine, Queen s University Kingston Community Health Center Faculty/Presenter
More informationDisclosures. Management of Chronic Pain for Cancer Survivors. University of Kentucky HealthCare, Lexington, KY
Management of Chronic Pain for Cancer Survivors Paul A. Sloan, M.D. Professor and Vice Chair for Research Associate Program Director, Pain Medicine Fellowship Department of Anesthesiology University of
More informationThe Role of the Emergency Department in the Opioid Epidemic. Scott G. Weiner, MD, MPH Department of Emergency Medicine Brigham and Women s Hospital
The Role of the Emergency Department in the Opioid Epidemic Scott G. Weiner, MD, MPH Department of Emergency Medicine Brigham and Women s Hospital Disclosures Treasurer, Massachusetts College of Emergency
More informationEpisode 74 Rationale Use of Opioids
Prepared by Dr. Keerat Grewal, edited by Dr. Anton Helman, Dec 2015 Episode 74 Rationale Use of Opioids Drs. David Juurlink & Reuben Strayer Opioid Use and Misuse Opioid misuse has become a major public
More informationCDC Guideline for Prescribing Opioids for Chronic Pain
National Center for Injury Prevention and Control CDC Guideline for Prescribing Opioids for Chronic Pain John Halpin, MD, MPH Medical Officer Division of Unintentional Injury Prevention Prescription Drug
More informationSafe and Competent Opioid Prescribing
MILITARY Military Safe and Competent Opioid Prescribing Education (M-SCOPE) Program Safe and Competent Opioid Prescribing For Providers Working with Veterans and Military Service Personnel Daniel P. Alford,
More information6/6/2018. Objectives. Outline. Rethinking Medication Treatment for Opioid Use Disorder
Rethinking Medication Treatment for Opioid Use Disorder International Conference on Opioids June 10, 2018 Dustin Patil, MD Fellow, Addiction Psychiatry Boston Medical Center John Renner, MD Professor of
More informationPain, Opioids and the EMR. Dr. Gordon Schacter April 12, 2018
Pain, Opioids and the EMR Dr. Gordon Schacter April 12, 2018 Faculty/Presenter Disclosure Faculty: Gordon Schacter Relationships with commercial interests: Grants/Research Support: None Speakers Bureau/Honoraria:
More informationSCG1 Evaluation of High Risk Pain Medications for MME
2018 SCG Health QCDR Measure Specifications 1 SCG1 Evaluation of High Risk Pain Medications for MME Percentage of patients aged 18 years and older prescribed and actively taking one or more high risk pain
More informationOpioid Management of Chronic (Non- Cancer) Pain
Optima Health Opioid Management of Chronic (Non- Cancer) Pain Guideline History Original Approve Date 5/08 Review/Revise Dates 11/09, 9/11, 9/13, 09/15, 9/17 Next Review Date 9/19 These Guidelines are
More informationKnock Out Opioid Abuse in New Jersey:
Knock Out Opioid Abuse in New Jersey: A Resource for Safer Prescribing GUIDELINE FOR PRESCRIBING OPIOIDS FOR CHRONIC PAIN IMPROVING PRACTICE THROUGH RECOMMENDATIONS CDC s Guideline for Prescribing Opioids
More informationTapering Opioids Best Practices*
Tapering Opioids Best Practices* Chuck Hofmann, MD, MACP 5 th Annual EOCCO Office Staff and Provider Summit September 28, 2017 Disclosure No Conflicts of Interest to report Learning Objectives Understand
More informationHOPE. Considerations. Considerations ISING. Safe Opioid Prescribing Guidelines for ACUTE Non-Malignant Pain
Due to the high level of prescription drug use and abuse in Lake County, these guidelines have been developed to standardize prescribing habits and limit risk of unintended harm when prescribing opioid
More informationDyslipidemia: Lots of Good Evidence, Less Good Interpretation.
Dyslipidemia: Lots of Good Evidence, Less Good Interpretation. G Michael Allan Evidence & CPD Program, ACFP Associate Professor, Dept of Family, U of A. CFPC CoI Templates: Slide 1 Faculty/Presenter Disclosure
More informationCan anesthesiologists reduce persistent opioid use after surgery?
Can anesthesiologists reduce persistent opioid use after surgery? David M. Dickerson, M.D Medical Director, Pain Management Services NorthShore University HealthSystem Department of Anesthesiology, Critical
More informationOPIOIDS: THE GOOD, THE BAD, AND EVERYTHING IN-BETWEEN
OPIOIDS: THE GOOD, THE BAD, AND EVERYTHING IN-BETWEEN ANTOINETTE BROWN, RPH LAUREL RAMER, 2019 PHARMD CANDIDATE 2018 WYOMING CONFERENCE ON AGING LARAMIE, WY OCTOBER 3, 2018 OBJECTIVES 1. Understand the
More informationPoisoning Deaths vs. Motor Vehicle Related Injury Deaths, MA Residents ( )
Source: National Vital Statistics Poisoning Deaths vs. Motor Vehicle Related Injury Deaths, MA Residents (1997 2008) The source of the data is: Registry of Vital Records and Statistics, MA Department of
More informationStriking a Balance: a provider perspective.
Striking a Balance: a provider perspective kpfeifer@chcf.org Beth s story 38 years old, erratically employed Counseling doesn t help Chronic low back pain after car accident 8 Vicodin/day grew to 180 mg
More informationAETNA BETTER HEALTH Prior Authorization guideline for Narcotic Analgesic Utilization
AETNA BETTER HEALTH Prior Authorization guideline for Narcotic Analgesic Utilization Policy applies to all formulary and non-formulary schedules II V opioid narcotics, including tramadol and codeine, as
More informationPain Management After Outpatient Foot and Ankle Surgery
Pain Management After Outpatient Foot and Ankle Surgery Akash Gupta, MD; Austin Sanders, BA; Mackenzie Jones, BA; Kanupriya Kumar, MD; Matthew Roberts, MD; David Levine, MD; Mark Drakos, MD; Martin O Malley,
More informationCDC Guideline for Prescribing Opioids for Chronic Pain. Centers for Disease Control and Prevention National Center for Injury Prevention and Control
CDC Guideline for Prescribing Opioids for Chronic Pain Centers for Disease Control and Prevention National Center for Injury Prevention and Control THE EPIDEMIC Chronic Pain and Prescription Opioids 11%
More informationClinical Policy: Opioid Analgesics Reference Number: OH.PHAR.PPA.13 Effective Date: 10/2017 Last Review Date: 6/2018 Line of Business: Medicaid
Clinical Policy: Reference Number: OH.PHAR.PPA.13 Effective Date: 10/2017 Last Review Date: 6/2018 Line of Business: Medicaid Revision Log See Important Reminder at the end of this policy for important
More informationOPIOID IR COMBO DRUGS. Oxycodone-acetaminophen, Oxycodone-aspirin, Oxycodone-ibuprofen, Tramadolacetaminophen
RATIONALE FOR INCLUSION IN PA PROGRAM Background Apadaz (benzhydrocodone-acetaminophen), codeine-acetaminophen, dihydrocodeine-caffeineacetaminophen, hydrocodone-acetaminophen, hydrocodone-ibuprofen, oxycodoneacetaminophen,
More informationCanadian Guideline for Opioids for Chronic Non-Cancer Pain. Speaker Disclosure. Objectives. Canadian Guideline for Opioids for Chronic Non-Cancer Pain
Canadian Guideline for Opioids for Chronic Non-Cancer Pain John Fraser Community Hospital Program New Glasgow November 1, 2017 This speaker has been asked to disclose to the audience any involvement with
More informationTITLE: Long-acting Opioids for Chronic Non-cancer Pain: A Review of the Clinical Efficacy and Safety
TITLE: Long-acting Opioids for Chronic Non-cancer Pain: A Review of the Clinical Efficacy and Safety DATE: 27 August 2015 CONTEXT AND POLICY ISSUES Chronic non-cancer pain (CNCP) of neuropathic or proprioceptive
More informationOxycodone dosage for cats Chest xray to rule out TB icd10 code AI horinam jabe emesis ICD Disawar ka number kya hai Indaba zamabhebhana Sitemap
Oxycodone dosage for cats Chest xray to rule out TB icd10 code AI horinam jabe emesis ICD Disawar ka number kya hai Indaba zamabhebhana Sitemap 11-7-2017 Continued. Never change or stop taking any opioid
More informationAppropriate Opioid Prescribing for Acute Pain after Surgery
Appropriate Opioid Prescribing for Acute Pain after Surgery Richard J. Barth Jr. Professor of Surgery Chief, Section of General Surgery Dartmouth Hitchcock Medical Center American Urologic Association
More informationNew Guidelines for Prescribing Opioids for Chronic Pain
New Guidelines for Prescribing Opioids for Chronic Pain Andrew Lowe, Pharm.D. CAPA Meeting October 6, 2016 THE EPIDEMIC Chronic Pain and Prescription Opioids 11% of Americans experience daily (chronic)
More informationUSE OF BUPRENORPHINE FOR CHRONIC PAIN
Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences USE OF BUPRENORPHINE FOR CHRONIC PAIN MARK SULLIVAN, MD, PHD PSYCHIATRY AND BEHAVIORAL SCIENCES ANESTHESIOLOGY AND
More informationPain Management Wrap-Up Chronic Care. David Tauben, MD Medicine Anesthesia & Pain Medicine
Pain Management Wrap-Up Chronic Care David Tauben, MD Medicine Anesthesia & Pain Medicine Objectives Understand that Pain is Complex Know how to select Rx based on Pain type Be aware that Rx only reduces
More informationAn overview of Medication Assisted Treatment (MAT) and acute pain management on MAT
An overview of Medication Assisted Treatment (MAT) and acute pain management on MAT Goals of Discussion Recognize opioid use disorder (OUD) Discuss the pharmacology of medication assisted treatments (MAT)
More informationManaging Pain in Individuals with Serious Illness and Comorbid Substance Use Disorder
Managing Pain in Individuals with Serious Illness and Comorbid Substance Use Disorder Presented by: Kathleen Broglio, DNP, ANP-BC, ACHPN, CPE, FPCN on December 1, 2016 Webcast Questions and Answers (Answers
More informationNavigating Pain Management during the Opioid Epidemic: Focus Group Findings
Navigating Pain Management during the Opioid Epidemic: Focus Group Findings David Cameron Oregon Health & Science University Department of Family Medicine, Portland, OR Funding received from AHRQ (5R18HS024227-02)
More informationMAT IN PREGNANCY KAYLA LIFE STAGE 1: ADOLESCENCE LIFE STAGE 2: EARLY ADULTHOOD. family History of addiction. addiction to oral opioids
MAT IN PREGNANCY R. COREY WALLER MD, MS PRINCIPAL, HEALTH MANAGEMENT ASSOCIATES FACULTY, INSTITUTE FOR HEALTHCARE INNOVATION (IHI) CHAIR, LEGISLATIVE ADVOCACY COMMITTEE, ASAM KAYLA LIFE STAGE 1: ADOLESCENCE
More informationValue of Abuse-Deterrent Opioids. For your personal use. Not for further distribution.
Value of Abuse-Deterrent Opioids HHS Data Show that Prescription Opioid Abuse Continues To Be a Serious Public Health Issue At least half of all opioid overdose deaths in the United States (US) involve
More informationIMPLEMENTING RECOVERY ORIENTED CLINICAL SERVICES IN OPIOID TREATMENT PROGRAMS PILOT UPDATE. A Clinical Quality Improvement Program
IMPLEMENTING RECOVERY ORIENTED CLINICAL SERVICES IN OPIOID TREATMENT PROGRAMS PILOT UPDATE A Clinical Quality Improvement Program Today: National completion rates for OTP s hover between 11 14% Retention
More informationOHSU. Vermont s Response to the Opioid Crisis Alumni Scientific Session Dr. Harry Chen Commissioner of Health (former)
Vermont s Response to the Opioid Crisis Alumni Scientific Session Dr. Harry Chen Commissioner of Health (former) 2011-2017 May 12, 2017 The Problem Opioids are powerful and useful pain killers. Opioids
More informationFighting the Good Fight: How to Convert Opioids Just Right!
Fighting the Good Fight: How to Convert Opioids Just Right! Tanya J. Uritsky, PharmD, BCPS, CPE Clinical Pharmacy Specialist - Pain Medication Stewardship Hospital of the University of Pennsylvania - Philadelphia,
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Effective Date: 04.18 Last Review Date: 04.18 Line of Business: Medicaid- AHCCCS Revision Log See Important Reminder at the end of this policy for important regulatory and legal information. Description
More informationUniversal Precautions and Opioid Risk. Assessment. Questions: How often do you screen your patients for risk of misuse when prescribing opioids?
Learning objectives 1. Identify the contribution of psychosocial and spiritual factors to pain 2. Incorporate strategies for identifying and mitigating opioid misuse 3. Incorporate non-pharmaceutical modalities
More informationManagement of Pain - A Comparison of Current Guidelines
Management of Pain - A Comparison of Current Guidelines The Centers for Disease Control and Prevention (CDC) released a guideline in 2016 regarding the prescribing of opioids for chronic non-cancer pain
More informationTHE PROS & CONS OF THE CDC GUIDELINES FOR SAFE OPIOID PRESCRIBING
THE PROS & CONS OF THE CDC GUIDELINES FOR SAFE OPIOID PRESCRIBING Ernest J Dole, PharmD, PhC, FASHP, BCPS Clinical Pharmacist University of New Mexico Hospitals And Clinical Associate Professor University
More informationUnitedHealthcare Pharmacy Clinical Pharmacy Programs
UnitedHealthcare Pharmacy Clinical Pharmacy Programs Program Number 2017 P 2099-5 Program Prior Authorization/Medical Necessity Buprenorphine Products (Pain Indications) Medication Belbuca (buprenorphine
More informationMOA: Practice Managers Program. Presented by: Kimber Debelak, CMC, CMOM, CMIS. May 17, zpain Management. & New Opioid Laws
MOA: Practice Managers Program Presented by: Kimber Debelak, CMC, CMOM, CMIS May 17, 2018 Pain Management & New Opioid Laws Objectives and Educational Statement Objectives To understand the need for new
More informationSubject: Pain Management (Page 1 of 7)
Subject: Pain Management (Page 1 of 7) Objectives: Managing pain and restoring function are basic goals in helping a patient with chronic non-cancer pain. Federal and state guidelines require that all
More informationThe Challenges of Opioid Dispensing
The Challenges of Opioid Dispensing William R. Kirchain, PharmD, CDE XULA Instructor, Pharmacy Law President, Louisiana Pharmacists Association CDC Guideline for Prescribing Opioids for Chronic Pain United
More informationClinical Policy: Opioid Analgesics Reference Number: CP.PMN.97 Effective Date: Last Review Date: 02.19
Clinical Policy: Reference Number: CP.PMN.97 Effective Date: 02.11 Last Review Date: 02.19 Line of Business: Medicaid Revision Log See Important Reminder at the end of this policy for important regulatory
More informationClinical Policy: Opioid Analgesics Reference Number: CP.PMN.97 Effective Date: Last Review Date: 02.18
Clinical Policy: Reference Number: CP.PMN.97 Effective Date: 02.11 Last Review Date: 02.18 Line of Business: Medicaid Revision Log See Important Reminder at the end of this policy for important regulatory
More informationMedications for Opioid Use Disorder. Charles Brackett, MD, MPH General Internal Medicine, DHMC
Medications for Opioid Use Disorder Charles Brackett, MD, MPH General Internal Medicine, DHMC Opioid Related Deaths are on the Rise in the US National Vital Statistics System Mortality File Deaths are
More informationThe Difficult Patient: Risk Mitigation Strategies
The Difficult Patient: Risk Mitigation Strategies C. Scott Anthony, D.O. Pain Management of Tulsa 1 Opioid Backlash National emergency Opioids not indicated for chronic pain Forces pushing for reduction
More informationNew, True & Poo. Faculty/Presenter Disclosure
New, True & Poo Unpleasant Truths Comforting Lies Tina, Mike K, Adrienne, Mike A, Evidence & CPD Program, Alberta College of Family Physicians Department of Family Medicine, University of Alberta Faculty/Presenter
More informationLegal Issues in Opioid Prescribing
Legal Issues in Opioid Prescribing Joanne L. Martin, J.D. Legal Counsel Mayo Clinic Rochester, Mn 2015 MFMER slide-1 Conflict of Interest I have no relevant financial relationships to disclose I will not
More informationOpioid Prescribing: Avoiding Pitfalls and Employing Safe Strategies. Essentials in Pain Management: Update 2017 Michael Weinberger MD
Opioid Prescribing: Avoiding Pitfalls and Employing Safe Strategies Essentials in Pain Management: Update 2017 Michael Weinberger MD The Problem 2015 52,404 2016 64,070 20% increase The Problem Drug
More informationHydrocodone Combination Analgesic Products Clinical Impact of a Schedule Change
Hydrocodone Combination Analgesic Products Clinical Impact of a Schedule Change Frederick A. Curro D.M.D., Ph.D. Director, PEARL Practice Based Research Network Director, Regulatory Affairs, Bluestone
More informationIncrease in Opioid Related Deaths What the Data Can Tell us. Ontario Methadone Prescriber s Conference November 7, 2014 Tara Gomes
Increase in Opioid Related Deaths What the Data Can Tell us Ontario Methadone Prescriber s Conference November 7, 2014 Tara Gomes Objectives Prescription Opioid Misuse and Abuse: How did we get here? Opioid
More informationCanadian Guideline for Opioids for Chronic Non-Cancer Pain. Speaker Disclosure. Objectives. Canadian Guideline for Opioids for Chronic Non-Cancer Pain
Canadian Guideline for Opioids for Chronic Non-Cancer Pain John Fraser Community Hospital Program North Sydney April 12, 2018 This speaker has been asked to disclose to the audience any involvement with
More informationMAT 101: TREATMENT OF OPIOID USE DISORDER
MAT 101: TREATMENT OF OPIOID USE DISORDER WITH SPECIAL EMPHASIS ON BUPRENORPHINE/NALOXONE ICADD May 22, 2018 Alicia Carrasco, MD Debby Woodall, LCSW, ACADC Magni Hamso, MD, MPH Terry Reilly Health Services
More informationOpioids: What You Should Know About Opioid Prescribing. Denis G. Patterson, DO Nevada State Medical Association October 19, 2016
Opioids: What You Should Know About Opioid Prescribing Denis G. Patterson, DO Nevada State Medical Association October 19, 2016 Contact Information Denis G. Patterson, DO Nevada Advanced Pain Specialists
More informationScope of the Opiate Problem 6/5/18. Chronic Pain Management and the Use of Opioid Medications: The CDC Guideline and Beyond. Overview.
Chronic Pain Management and the Use of Opioid Medications: The CDC Guideline and Beyond David Anisman, MD Medical Director, Farmington Health Center (Primary Care) Associate Medical Director, Community
More informationLong-Acting Opioid. Policy Number: Last Review: 12/2017 Origination: 09/2013 Next Review: 09/2018
Long-Acting Opioid Policy Number: 5.02.519 Last Review: 12/2017 Origination: 09/2013 Next Review: 09/2018 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide coverage for long-acting
More informationReadopt with amendment Med 502, effective (Document #11090), to read as follows:
Adopted Rules 11-2-16 1 Readopt with amendment Med 502, effective 5-3-16 (Document #11090), to read as follows: PART Med 502 OPIOID PRESCRIBING Med 502.01 Applicability. This part shall apply to the prescribing
More informationOregon s PDMP: An epidemiological assist tool
Oregon s PDMP: An epidemiological assist tool Todd Beran Center for Prevention and Health Promotion Oregon Health Authority PDMP TTAC Webinar February 13, 2013 1 Acknowledgements Lisa Millet, MSH, Section
More informationOpioid Dependence and Buprenorphine Management
Opioid Dependence and Buprenorphine Management Kevin Kapila, MD Fenway Health Medical Director of Behavioral Health Instructor in Medicine Harvard Medical School Learning Objectives Understand the rationale
More informationDrug Use Evaluation: Short Acting Opioids (SAO)
Drug Use Evaluation: Short Acting Opioids (SAO) Summary Short acting opioid analgesics are one of the most prescribed (top 10) and highest cost (top 20) medication classes for the Oregon Fee For Service
More informationOpioid Prescribing Guidelines for Patients in the Emergency Department
Opioid Prescribing Guidelines for Patients in the Emergency Department and Immediate Care Centers These guidelines are meant to assist clinicians in treating patients with acute and chronic pain in the
More information